Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1991 | 09-1991 | 06-1991 | 03-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,317,600 | 673,500 | 675,800 | 608,900 | 870,300 |
| Marketable Securities | 583,100 | 201,500 | 167,900 | 131,500 | 782,800 |
| Receivables | 1,403,900 | 1,494,500 | 2,039,100 | 2,048,700 | 1,377,200 |
| Inventories | 1,171,500 | 1,188,700 | 1,202,100 | 1,180,400 | 1,142,600 |
| Other current assets | 332,100 | 804,900 | 276,300 | 286,700 | 263,000 |
| TOTAL | $4,808,200 | $4,363,100 | $4,361,200 | $4,256,200 | $4,435,900 |
| Non-Current Assets | |||||
| PPE Net | 2,381,000 | 3,822,000 | 3,702,000 | 3,724,600 | 3,616,300 |
| Investments And Advances | 1,337,800 | 1,300,600 | 1,227,100 | 1,303,000 | 1,422,700 |
| Other Non-Current Assets | 1,107,600 | 1,101,300 | 1,075,800 | 1,086,000 | 1,083,600 |
| TOTAL | $4,826,400 | $6,223,900 | $6,004,900 | $6,113,600 | $6,122,600 |
| Total Assets | $9,634,600 | $9,008,000 | $8,825,600 | $8,813,600 | $9,052,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 17,500 | 17,500 | 0 | 0 |
| Accounts payable and accrued liabilities | 462,900 | 401,300 | 411,000 | 427,400 | 450,300 |
| Accrued Expenses | 287,600 | 267,000 | 267,300 | 267,100 | 283,600 |
| Other current liabilities | 620,400 | 610,700 | 724,200 | 573,300 | 576,000 |
| TOTAL | $3,420,500 | $3,227,900 | $3,261,700 | $2,826,500 | $3,116,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 396,600 | 148,900 | 157,200 | 177,200 | 193,300 |
| Other Non-Current Liabilities | 456,300 | 160,100 | 157,300 | 162,000 | 156,700 |
| TOTAL | $1,187,800 | $710,300 | $736,000 | $808,900 | $843,100 |
| Total Liabilities | $4,573,900 | $3,906,100 | $3,966,000 | $3,605,900 | $3,960,000 |
| Shareholders' Equity | |||||
| Common Shares | 33,200 | 33,200 | 33,100 | 33,100 | 16,500 |
| Retained earnings | 4,794,900 | 4,903,000 | 4,627,700 | 4,668,000 | 4,509,900 |
| Other shareholders' equity | 157,700 | 75,600 | 85,900 | 258,400 | 256,000 |
| TOTAL | $5,026,300 | $5,069,800 | $4,827,900 | $5,178,200 | $5,092,000 |
| Total Liabilities And Equity | $9,600,200 | $8,975,900 | $8,793,900 | $8,784,100 | $9,052,000 |